Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
P096 Effectiveness of human cytochrome P450 1A1 expressed in eukaryotic and prokaryotic systems in oxidation and DNA adduct formation by benzo[a]pyrene Stiborová Marie, Moserová Michaela, Indra Radek, Frei Eva, Schmeister Heinz H., Arlt Volker M. Department of Biochemistry, Faculty of Science, Charles University in Prague, Albertov 6, 128 43 Prague 2; Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Analytical and Enviromental Sciences Division, MRC-HPA Centre for Enviroment and Health, King´s College London, London SE1 9NH, United Kingdom E-mail: [email protected] Sekce: Xenobiochemie a molekulární toxikologie Benzo[a]pyrene (BaP) is a human carcinogen that covalently binds to DNA after activation by cytochrome P450 (CYP), predominantly by CYP1A1. Here, we investigated a role of human CYP1A1 in BaP oxidation and formation of BaP-DNA adducts. Human CYP1A1 expressed in the eukaryotic system (microsomes of insect cells transfected with human CYP1A1 and NADPH:CYP reductase, POR - Supersomes™) and in the prokaryotic system of Escherichia coli cells (E. coli membranes containing over-expressed human CYP1A1 and POR Bactosomes) were used as models. In the eukaryotic cells, CYP enzymes, including CYP1A1, are components of a mixed-function oxidase (MFO, monooxygenase) system located in the membrane of endoplasmic reticulum (microsomes). This enzymatic system also contains other enzymes, the multidomain flavoprotein POR and cytochrome b5 accompanied by its NADH:cytochrome b5 reductase (CBR). Because Supersomes™ are microsomes, they contain beside the over-expressed human recombinant CYP1A1 with POR, also basic levels of CBR, microsomal epoxide hydrolase (mEH) and cytochrome b5. In the case of the prokaryotic cells of E. coli transfected with human CYP1A1 and POR, this CYP together with POR are expressed in the cell membrane that does not contain any other enzymes of the MFO monooxygenase system. BaP-9,10-dihydrodiol, BaP-7,8-dihydrodiol, BaP-1,6-dione, BaP3,6-dione, BaP-9-ol, BaP-3-ol, a metabolite of unknown structure, and two BaP-DNA adducts were generated by the CYP1A1-Supersomes™ system, both in the presence of NADPH and in the presence of NADH. BaP-3-ol as the major metabolite, BaP-9-ol, BaP-1,6-dione, BaP3,6-dione, an unknown metabolite, and at least three BaP-DNA adducts were observed in the system using CYP1A1 expressed with POR in E. coli plus NADPH, a cofactor of POR. Because of the absence of mEH, no dihydrodiol metabolites of BaP were formed. When CYP1A1 in E. coli membrane was incubated with a cofactor of CBR, NADH, no BaP metabolites as well as BaP-DNA adducts were detectable. Only low levels of BaP-DNA adducts were found in the presence of NADH when purified CBR and cytochrome b5 were added into the E. coli enzymatic system. This finding suggests a role of the NADH/cytochrome b5/CBR system as sole donor of electrons to CYP1A1 in its reaction cycle substituting the system of POR with NADPH. The results found indicate some limitation in the use of human CYP1A1 expressed in cells of the prokaryotic organism, E. coli. The differences between enzyme (protein) compositions of the cell membrane of E. coli from those of the microsomal membrane of Supersomes™, absenting several components of the CYP monooxygenase system, seem to be responsible for the found results. Supported by GACR (grant 15-02328S) and Charles University (grant UNCE 204025/2012).